EMBLA MEDICAL HF. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.7 DKK | +1.99% |
|
+3.02% | +11.84% |
| Apr. 23 | Transcript : Embla Medical hf., Q1 2024 Earnings Call, Apr 23, 2024 | |
| Apr. 23 | Embla Medical hf. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Embla Medical hf.
a7a31116bf8efaf2a2d.0meJhsL6FBmmaq-EvdDXHcYGun6_9lHHOmZDPo9-AEo.4D664qiocHifX-LJ6YniaZJ-jST8txXycF91U-00eHiqPcLtjK1Cd9Yd7g~a6b4d6ee0dc69f45725dbacac4cb94ce
Upcoming events on Embla Medical hf.
Past events on Embla Medical hf.
| 2024-04-23 01:00 am | Q1 2024 Earnings Release |
| 2024-03-13 05:00 am | Annual General Meeting |
| 2024-01-30 03:00 am | Q4 2023 Earnings Call |
| 2024-01-30 02:00 am | Q4 2023 Earnings Release |
| 2024-01-16 05:00 am | Acquisition of Fior & Gentz by Össur hf Call |
| 2024-01-07 | SEB Nordic Seminar |
| 2023-11-29 | Danske Bank Winter Seminar |
| 2023-10-24 03:00 am | Q3 2023 Earnings Call |
| 2023-10-24 12:00 am | Q3 2023 Earnings Release |
| 2023-09-05 | Goldman Sachs European Medtech Conference |
| 2023-08-23 | Nordea Small & Mid Cap Days |
| 2023-07-25 03:00 am | Q2 2023 Earnings Call |
| 2023-07-25 02:00 am | Q2 2023 Earnings Release |
| 2023-04-25 03:00 am | Q1 2023 Earnings Call |
| 2023-04-25 02:00 am | Q1 2023 Earnings Release |
| 2023-03-30 02:00 am | Capital Markets Day |
| 2023-03-13 | Carnegie Nordic Health Care Seminar |
| 2023-03-10 04:00 am | Annual General Meeting |
| 2023-03-08 08:45 am | ABGSC Investor Days |
| 2023-01-31 03:00 am | FY 2022 Earnings Call |
Past dividends on Embla Medical hf.
| 2020-03-12 | Annual 0.15 DKK |
| 2019-03-07 | Annual 0.14 DKK |
| 2018-03-08 | Annual 0.13 DKK |
| 2017-03-09 | Annual 0.12 DKK |
| 2016-03-10 | Annual 0.12 DKK |
| 2015-03-12 | 0.12 DKK |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 686 686 -0.01% | 630 634 -0.71% | 719 721 -0.26% | 719 721 -0.37% | 786 783 0.35% | 867 |
|
EBITDA Million USD | Released Forecast Spread | 150 143 4.83% | 93,0 105 -11.85% | 149 151 -1.42% | 128 125 2.81% | 139 143 -2.73% | 168 |
|
EBIT Million USD | Released Forecast Spread | 106 101 5.08% | 28,3 46,5 -39.14% | 97,3 102 -4.46% | 78,8 75,1 4.95% | 89,4 93,1 -3.99% | 115 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 90,3 92,2 -2.1% | 12,7 35,3 -63.96% | 86,6 91,1 -4.9% | 56,2 61,2 -8.16% | 76,0 75,5 0.7% | 108 |
|
Net income Million USD | Released Forecast Spread | 66,0 70,7 -6.64% | 6,21 24,8 -74.91% | 64,0 66,3 -3.41% | 42,5 46,0 -7.59% | 58,4 57,3 1.88% | 82,0 |
|
EPS DKK | Released Forecast Spread | 1,09 1,11 -1.28% | 0,12 0,35 -66.85% | 1,03 1,06 -2.66% | 0,71 0,85 -16.85% | 0,97 0,98 -1.69% | 1,26 |
| Announcement Date | 04/02/20 | 02/02/21 | 01/02/22 | 31/01/23 | 30/01/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 188 190 -1.03% | 170 174 -2.45% | 181 193 -6.46% | 177 184 -3.91% | 191 193 -1.11% | 181 183 -0.73% | 201 200 0.91% | 193 196 -1.37% | 210 211 -0.43% | 198 | 221 | 212 | 233 | |
|
EBITDA Million USD | Released Forecast Spread | 41,0 41,7 -1.73% | 27,0 30,9 -12.67% | 32,9 42,0 -21.69% | 35,0 35,2 -0.5% | 33,6 36,5 -7.91% | 28,2 29,9 -5.62% | 37,4 38,6 -3.1% | 36,0 35,4 1.6% | 37,0 42,5 -12.84% | 33,0 32,7 0.92% | 44,6 | 39,9 | 47,7 | |
|
EBIT Million USD | Released Forecast Spread | 25,9 29,4 -11.76% | 14,0 18,4 -23.89% | 20,5 28,7 -28.61% | 23,0 23,2 -0.68% | 21,2 23,6 -10.17% | 15,7 17,2 -8.54% | 25,0 25,2 -0.7% | 24,0 22,9 4.93% | 24,6 29,7 -16.93% | 19,5 | 31,3 | 26,7 | 34,2 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 23,5 26,9 -12.57% | 12,3 17,2 -28.26% | 19,1 26,4 -27.8% | 8,61 20,7 -58.35% | 16,2 20,3 -20.2% | 13,3 14,0 -5.3% | 20,6 21,4 -3.85% | 18,0 19,3 -6.55% | 24,2 23,5 2.85% | 15,7 | 27,3 | 22,7 | 30,2 | |
|
Net income Million USD | Released Forecast Spread | -11,0 | 17,6 23,2 -24.42% | 9,00 13,5 -33.33% | 14,1 20,5 -31.34% | 6,76 15,9 -57.39% | 12,9 15,7 -17.96% | 9,72 10,8 -9.95% | 15,8 17,0 -7.16% | 13,9 14,5 -4.18% | 19,0 19,0 0.23% | 8,00 13,0 -38.22% | 20,9 | 17,3 | 23,4 |
|
EPS DKK | Released Forecast Spread | 0,28 0,31 -11.34% | 0,15 0,19 -19.98% | 0,25 0,35 -28.42% | 0,12 0,26 -54.48% | 0,21 0,26 -21.86% | 0,16 0,16 -0.01% | 0,26 0,27 -6.69% | 0,23 0,16 42.54% | 0,31 0,30 1.78% | 0,20 | 0,34 | 0,28 | 0,38 | |
| Announcement Date | 23/07/20 | 01/02/22 | 26/04/22 | 21/07/22 | 25/10/22 | 31/01/23 | 25/04/23 | 25/07/23 | 24/10/23 | 30/01/24 | 23/04/24 | - | - | - |
| 2024-04-30 01:00 am | STRAUMANN HOLDING AG: Q1 2024 Earnings Release |
| 2024-05-05 | DEMANT A/S: Q1 2024 Sales and Revenue Release - Interim Management Statement |
| 2024-05-14 01:00 am | SONOVA HOLDING AG: Q4 2024 Earnings Release |
| 2024-07-23 01:00 am | EMBLA MEDICAL HF.: Q2 2024 Earnings Release |
| 2024-08-13 | STRAUMANN HOLDING AG: Q2 2024 Earnings Release |
| 2024-08-13 | DEMANT A/S: Q2 2024 Earnings Release |
| 2024-08-14 | EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q2 2024 Earnings Release (Projected) |
| 2024-08-14 | COCHLEAR LIMITED: Q4 2024 Earnings Release |
| 2024-08-21 | ANGELALIGN TECHNOLOGY INC.: Q2 2024 Earnings Release (Projected) |
| 2024-10-22 01:00 am | EMBLA MEDICAL HF.: Q3 2024 Earnings Release |
Past sector events for Embla Medical hf.
| 2024-04-23 01:00 am | EMBLA MEDICAL HF.: Q1 2024 Earnings Release |
| 2024-04-17 | EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-17 | EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.: Q4 2023 Earnings Release |
| 2024-03-18 | ANGELALIGN TECHNOLOGY INC.: Q4 2023 Earnings Release |
| 2024-02-27 01:00 am | STRAUMANN HOLDING AG: Q4 2023 Earnings Release |
| 2024-02-18 03:30 pm | COCHLEAR LIMITED: Q2 2024 Earnings Release |
| 2024-02-05 11:45 am | DEMANT A/S: Q4 2023 Earnings Release |
| 2024-01-30 02:00 am | EMBLA MEDICAL HF.: Q4 2023 Earnings Release |
| 2023-11-21 01:00 am | SONOVA HOLDING AG: Q2 2024 Earnings Release |
| 2023-11-06 | DEMANT A/S: Q3 2023 Sales and Revenue Release - Interim Management Statement |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EMBLA Stock
- Calendar Embla Medical hf.
